|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Gastrointestinal cancer
Trastuzumab
Combined with Irinotecan in Patients with HER2-Positive Metastatic Colorectal Cancer: A Phase II Single-Arm Study and Exploratory Biomarker Analysis
Ting Xu, Xicheng Wang, Ying Xin, Zhenghang Wang, Jifang Gong, Xiaotian Zhang, Yanyan Li, Congcong Ji, Yu Sun, Feilong Zhao, Depei Huang, Yuezong Bai, Jian Li, Lin Shen
Cancer Res Treat.
2023;55(2):626-635. Published online December 23, 2022 DOI:
https://doi.org/10.4143/crt.2022.1058
Web of Science 5
Crossref 5
Breast cancer
Real-World Evidence of
Trastuzumab
, Pertuzumab, and Docetaxel Combination as a First-Line Treatment for Korean Patients with HER2-Positive Metastatic Breast Cancer
Yong-Pyo Lee, Min-Sang Lee, HongSik Kim, Ji-Yeon Kim, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park
Cancer Res Treat.
2022;54(4):1130-1137. Published online January 17, 2022 DOI:
https://doi.org/10.4143/crt.2021.1103
Web of Science 2
Crossref 3
Gastrointestinal cancer
Trends in Chemotherapy Patterns and Survival of Patients with Advanced Gastric Cancer over a 16-Year Period: Impact of Anti-HER2–Targeted Agent in the Real-World Setting
Dong-Hoe Koo, Min-Hee Ryu, Mi-Yeon Lee, Heejung Chae, Eo Jin Kim, Mee-Sun Moon, Yoon-Koo Kang
Cancer Res Treat.
2021;53(2):436-444. Published online October 6, 2020 DOI:
https://doi.org/10.4143/crt.2020.725
Crossref 4
BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy
Sung-Bae Kim, In-Gu Do, Janice Tsang, Tae-You Kim, Yoon-Sim Yap, Gerardo Cornelio, Gyungyub Gong, Soonmyung Paik, Suee Lee, Ting-Ying Ng, Sarah Park, Ho-Suk Oh, Joanne Chiu, Joohyuk Sohn, Moonhee Lee, Young-Jin Choi, Eun Mi Lee, Kyong-Hwa Park, Christos Nathaniel, Jungsil Ro
Cancer Res Treat.
2019;51(4):1527-1539. Published online June 4, 2019 DOI:
https://doi.org/10.4143/crt.2018.598
Web of Science 4
Crossref 5
Early Decline in Left Ventricular Ejection Fraction Can Predict
Trastuzumab
-Related Cardiotoxicity in Patients with Breast Cancer: A Study Using 13 Years of Registry Data
Eun Kyoung Kim, Jinhyun Cho, Ji-Yeon Kim, Sung-A Chang, Sung-Ji Park, Jin Oh Choi, Sang Chol Lee, Jin Seok Ahn, Seung Woo Park, Young-Hyuck Im, Eun Seok Jeon, Yeon Hee Park
Cancer Res Treat.
2019;51(2):727-736. Published online September 4, 2018 DOI:
https://doi.org/10.4143/crt.2018.262
Web of Science 16
Crossref 15
Intrathecal
Trastuzumab
Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis
Won-Young Park, Han-Jo Kim, Kyoungha Kim, Sang-Byung Bae, Namsu Lee, Kyu-Taek Lee, Jong-Ho Won, Hee-Sook Park, Sang-Cheol Lee
Cancer Res Treat.
2016;48(2):843-847. Published online March 2, 2015 DOI:
https://doi.org/10.4143/crt.2014.234
Web of Science 18
Crossref 18
A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with
Trastuzumab
-Based Chemotherapy: In the Perspectives of Ethnicity and Histology
Jun Ho Yi, Jung Hun Kang, In Gyu Hwang, Hee Kyung Ahn, Hyun Jin Baek, Soon Il Lee, Do Hyoung Lim, Young-Woong Won, Jun Ho Ji, Hyo Song Kim, Sun Young Rha, Sung Yong Oh, Kyung Eun Lee, Taekyu Lim, Chi Hoon Maeng, Moon Jin Kim, Seung Tae Kim, Jeeyun Lee, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Se Hoon Park
Cancer Res Treat.
2016;48(2):553-560. Published online August 10, 2015 DOI:
https://doi.org/10.4143/crt.2015.155
Web of Science 17
Crossref 15
Serum HER2 as a Response Indicator to Various Chemotherapeutic Agents in Tissue HER2 Positive Metastatic Breast Cancer
Sun-Young Kong, Do Hoon Lee, Eun Sook Lee, Susan Park, Keun Seok Lee, Jungsil Ro
Cancer Res Treat.
2006;38(1):35-39. Published online February 28, 2006 DOI:
https://doi.org/10.4143/crt.2006.38.1.35
Crossref 12
The Prognostic Significance of the Overexpression of HER-2/ neu in Korean Gastric Carcinomas and the In Vitro Effects of Anti-HER-2/neu Antibody on Cell Growth in the Gastric Carcinoma Cell Lines
Seock Ah Im, Kyung Eun Lee, Eunmi Nam, Seung Hyun Nam, Do Yeun Kim, Chu Myong Seong, Hae Young Park, Woon Sup Han, Ju Young Seoh, Soon Nam Lee
Cancer Res Treat.
2003;35(2):109-116. Published online April 30, 2003 DOI:
https://doi.org/10.4143/crt.2003.35.2.109
Crossref 3
Trastuzumab
Biosimilar (HLX02), Pertuzumab Plus Chemotherapy in Patients with HER2-Positive Metastatic Breast Cancer after Progression of
Trastuzumab
: A Prospective, Phase II Study
Ruyan Zhang, Xiaoran Liu, Guohong Song, Yan Zhang, Huiping Li
Received October 20, 2023 Accepted December 19, 2023 Published online December 20, 2023
DOI:
https://doi.org/10.4143/crt.2023.1151
[Accepted]
1
Journal Impact Factor 4.6